Yes $ONCS has definitely treated the patients as they enroll. That is why Merkel Cell and Cutaneous have early results. These two cancers are rare but deadly and there has been difficulty earlier in finding all the Patients. So they were treated as they came. No need to wait. Both clinical trials are expected to complete their full enrollment this year.
News 
Market Data 
Discover 
